Get startedLog in
    Picture of Agios Pharmaceuticals logo

    AGIO — Agios Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Agios’ Pyrukynd® (Mitapivat) Approved For Adults With Thalassemia In The United Arab Emirates

    Picture of Agios Pharmaceuticals logoAgios Pharmaceuticals
    02/03/2026 14:15
    March 2 (Reuters) - Agios Pharmaceuticals Inc AGIO.O:

AGIOS’ PYRUKYND® (MITAPIVAT) APPROVED FOR ADULTS WITH THALASSEMIA IN THE UNITED ARAB EMIRATES

AGIOS PHARMACEUTICALS INC - NEWBRIDGE TO MANAGE PYRUKYND COMMERCIALIZATION IN GULF

Source text: ID:nGNX46F805

Further company coverage: AGIO.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Agios Pharmaceuticals

    See all news